Skip to main content
Clinical Trials/PACTR202209718136908
PACTR202209718136908
Recruiting
Phase 2

The effectiveness of pain neuroscience education in the treatment of recreational marathon runners with chronic running related knee injuries

Tyren Naidoo0 sites60 target enrollmentJuly 19, 2022

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Musculoskeletal Diseases
Sponsor
Tyren Naidoo
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 19, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Tyren Naidoo

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria
  • Signed informed consent.
  • Participants aged 18 to 65 years (Knechtle and Nikolaidis 2018; Larsen et al. 2020\).
  • Participants who are male or female with symptomatic chronic knee pain (greater than 3 months duration).
  • Participants with a weekly training volume between 30 and 80km/week (Rasmussen et al. 2013\).
  • Participants who had completed 2 or more marathon events within the past 2 years (virtual and non\-virtual).
  • Participants with a score greater than 40 on the central sensitization inventory scale (CSI) (Mayer et al. 2012\).

Exclusion Criteria

  • Exclusion Criteria
  • Professional and elite marathon runners (Rüst et al. 2011\).
  • Participants who have had previous total knee replacement or any other lower limb surgery within the past six months of the affected knee, co\-existing inflammatory, metabolic or neurologic disease (Messier et al. 2008; Lluch et al. 2018\).
  • Participants who have contraindications to chiropractic care and PNE.
  • Participants who have previously received chiropractic care and/or PNE can require a 3 month wash out period before they can be eligible to enter the study.
  • Participation in other pain trials prior (3 months) to recruitment.
  • Lack of the ability to adhere to the protocol, cognitive impairment, illiteracy or unable to speak English (Lluch et al. 2018\).

Outcomes

Primary Outcomes

Not specified

Similar Trials